2025-01179Notice

Expedited Program for Serious Conditions-Accelerated Approval of Drugs and Biologics; Draft Guidance for Industry; Extension of Comment Period

Published Date: 1/17/2025

Notice

Summary

The FDA is giving drug makers and the public more time to share their thoughts on new rules that speed up approval for important medicines treating serious illnesses. This extension means comments are now due by March 6, 2025, helping ensure everyone’s voice is heard before final decisions. If you’re involved in developing or using these drugs, this extra time could impact how quickly new treatments reach patients.

No Economic Impacts Identified for this Document

Personalized for You

How does this regulation affect your finances?

Personalize government policy and PRIA will tell you what this federal register document means for your household, plus every other regulation we track. PRIA reads each provision against your financial profile to show you exactly what matters to your wallet.

Key Dates

Published Date
Effective Date
1/17/2025
3/6/2025

Department and Agencies

Department
Independent Agency
Source: View HTML

Related Federal Register Documents

Previous / Next Documents

Back to Federal Register